Drug Profile
Calcitonin human-salmon hybrid - Tsumura
Alternative Names: TJN 135Latest Information Update: 22 Aug 2002
Price :
$50
*
At a glance
- Originator Tsumura
- Class Osteoporosis therapies
- Mechanism of Action Calcitonin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Postmenopausal osteoporosis
Most Recent Events
- 22 Aug 2002 Discontinued - Phase-II for Postmenopausal osteoporosis in Japan (unspecified route)
- 19 May 1998 New profile
- 19 May 1998 Phase-II clinical trials for Postmenopausal osteoporosis in Japan (Unknown route)